Climb Bio (CLYM) Share-based Compensation (2020 - 2026)

Climb Bio has reported Share-based Compensation for 7 years, with the latest figure at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 20.62% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $7.6 million (up 7.35% YoY), and the FY2025 full-year result was $8.1 million, up 44.93% from the prior year.
• Share-based Compensation for Q1 2026 stood at $1.6 million, up from $1.0 million in the prior quarter.
• The five-year high for Share-based Compensation was $10.2 million in Q1 2023, with the low at $465000.0 in Q1 2024.
• Historically, Share-based Compensation has averaged $2.1 million across 5 years, with a median of $1.6 million in 2026.
• Annual changes were most pronounced in 2023 — Share-based Compensation jumped 560.03% — and 2024, when it sank 95.43%.
• Climb Bio's Share-based Compensation stood at $1.9 million in 2022, then tumbled by 36.57% to $1.2 million in 2023, then surged by 37.94% to $1.7 million in 2024, then tumbled by 37.09% to $1.0 million in 2025, then surged by 53.88% to $1.6 million in 2026.
• The last three Share-based Compensation figures came in at $1.6 million (Q1 2026), $1.0 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.